Catalyst Wire Dossier Catalyst Wire Dossier

Topical NF-kappaB decoy

· Anesiva, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical NF-kappaB decoy, covering 2008-11-19 to 2008-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis [Phase 1, Phase 2]

See pricing